Skip to main content

Ganot Ilan's Form 4 filing

Solid Biosciences Inc. (SLDB) · filed Jan 29, 2025

Accession no.
0000950170-25-010625
Filed
Jan 29, 2025
Trade date
Jan 27-28, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $447.84. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ganot IlanCIK 0001727460Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 27, 2025Common StockMOption exerciseAcquired+388––11,833Indirect
Jan 28, 2025Common StockSSaleDisposed−144$3.11−$447.8411,689Indirect
Jan 27, 2025Common StockMOption exerciseAcquired+3,883––98,690Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 27, 2025Common StockMOption exerciseDisposed−388$0.00$0389Indirect
Jan 27, 2025Common StockMOption exerciseDisposed−3,883$0.00$03,884Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)